Cardiovascular Sciences, Inc.
Cardiovascular Sciences, Inc. Approaches Launch of Next Phase
Published in Lab Law Weekly, June 27th, 2008
The board of directors of Cardiovascular Sciences, Inc. (Pink Sheets:CVSC) (the "Company") is eager to announce that it is entering into the next phase of development with its partnership with MedTech Enterprises. Cardiovascular Sciences, Inc. is a client company of the award-winning University of Central Florida's Technology Incubator program. MedTech Enterprises is the company's division readying to spring forth with a retail internet program to market a premium antioxidant, anti-aging nutritional supplement.
Over the past six weeks, the company has arranged for the production of a premium antioxidant supplement containing nutrients scientifically proven to reduce...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2008-06-27)
More Articles from Lab Law Weekly
- AARP New York State
AARP NY Key Vote News Alert: AARP Dismayed by Senate Vote to Block Medicare Improvement Bill - AARP Pennsylvania
AARP PENNSYLVANIA NEWS ALERT: AARP Dismayed by Senate Vote to Block Medicare Improvement Bill - Addax Petroleum Corporation
Addax Petroleum Statement - Allergan, Inc.
Allergan Announces Agreement to Acquire Aczone Gel 5% - ALM Media, Inc.
ALM Events Announces Fifth Annual Cosmeceuticals Conference - American Chemistry Council
Acc Pleased by Court's hon Decision - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
